A coalition of state attorneys general, including those in Pennsylvania and New Jersey, has reached agreements with two ...

About 18.7 million people will save $7.4 billion next year alone thanks to changes to Medicare drug benefits, the ...

The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), Alzheimer's, and Parkinson's disease continues to rise, especially for MS ...

Walgreens has agreed to pay $100 million to settle a proposed class action lawsuit accusing it of fraudulently overcharging ...

Ozempic is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to help with blood sugar control ...

Business owners in downtown Fredericton say they are increasingly frustrated with a rise in break-ins, theft, vandalism, open ...

Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, ...

The Alzheimer's disease drug Kisunla will face major reimbursement challenges in the U.K. after the cost-effectiveness ...

The influence of AI in drug development has gained such importance that it has been termed a revolution. Let’s explore how ...

Illegal drugs are big business inside New Mexico's primary federal detention center 70 miles west of. The prices are exorbitant, with inmates reporting leaving the private facility with more than $50, ...

A panel of Maryland lawmakers has approved a plan to enable a state board to cap the cost that state and local governments ...

Most U.S. states do not currently cover highly sought after weight-loss drugs from Novo Nordisk and Eli Lilly in their ...